Net profit of Trident Texofab rose 33.33% to Rs 1.00 crore in the quarter ended September 2024 as against Rs 0.75 crore during the previous quarter ended September 2023. Sales rose 14.01% to Rs 26.45 crore in the quarter ended September 2024 as against Rs 23.20 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 26.45 | 23.20 | 14 |
OPM % | -1.06 | 5.43 | - |
PBDT | 1.35 | 1.22 | 11 |
PBT | 0.94 | 0.81 | 16 |
NP | 1.00 | 0.75 | 33 |